The Medicines and Healthcare products Regulatory Agency (MHRA) has issued a drug alert to healthcare professionals informing them of a precautionary recall of certain batch numbers of Seton Products Ltd Woodward’s Gripe Water. [click link for full article]
A wearable hemodialysis device aimed at improving the quality of life of kidney failure patients has had some promising results, according to an article published in The Lancet, this week’s edition. Approximately 1.3 million people globally have chronic kidney failure that requires either renal transplantation or dialysis - for such patients, the established treatment is hemodialysis. [click link for full article]
European Parliament legislation will improve the regulation of pediatric drug treatment, according to an Editorial in the British Medical Journal (BMJ), this week’s issue. Author, Professor Imti Choonara, University of Nottingham, UK, explains that over the past decade studies have indicated that the use of unlicensed and off-label drugs to treat children is widespread. [click link for full article]
The European Medicines Agency (EMEA) has been formally notified by Guerbet of its decision to withdraw its application for a centralised marketing authorisation for the medicine Sinerem (superparamagnetic iron oxide nanoparticles stabilised with dextran and sodium citrate). [click link for full article]
Mevacor, a drug used for treating high cholesterol (a statin drug), should not change status from prescription only to over-the-counter (OTC), a Food and Drug Administration (FDA) panel recommended today. The Panel believes patients may not know how to use the drug correctly. This is the third time that Mevacor makers, Merck & Co, apply for OTC status. [click link for full article]
Recent Comments